Arix Bioscience PLC
LSE:ARIX
Arix Bioscience PLC
LSE:ARIX
Price:
142 GBX
Market Closed
Updated:
May 5, 2024
Arix Bioscience PLC
Operating Income
|
Arix Bioscience PLC
Operating Income Peer Comparison
Comparables:
JHG
III
SDR
ICP
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arix Bioscience PLC
LSE:ARIX
|
Operating Income
-£5.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Janus Henderson Group PLC
NYSE:JHG
|
Operating Income
$483.7m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
3i Group PLC
LSE:III
|
Operating Income
£4.5B
|
CAGR 3-Years
84%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
|
|
Schroders PLC
LSE:SDR
|
Operating Income
£552.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Intermediate Capital Group PLC
LSE:ICP
|
Operating Income
£517.7m
|
CAGR 3-Years
31%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
See Also
What is Arix Bioscience PLC's Operating Income?
Operating Income
-5.3m
GBP
-5.3m
GBP
Based on the financial report for Dec 31, 2022, Arix Bioscience PLC's Operating Income amounts to -5.3m GBP.
What is Arix Bioscience PLC's Operating Income growth rate?
Operating Income CAGR 5Y
10%
10%
Over the last year, the Operating Income growth was -12%. The average annual Operating Income growth rates for Arix Bioscience PLC have been 17% over the past three years , 10% over the past five years .
You don't have any saved screeners yet
